CNP and pulmonary arterial hypertension: Corroborating these findings, fold change (FC) analyses of the metabolomics data revealed that CNP pretreatment significantly prevented the stimulatory effects of PDGF-BB on the levels of carbamoyl aspartate, deoxy-Cytidine and especially of carbamoyl phosphate in PAH pericytes (Fig. 4g).